Health Catalyst insider plans sale of 35K shares

A Rule 144 notice reports Benjamin Albert’s planned sale of 35,244 HCAT shares and recent restricted stock sales.

Available on EDGAR 09/10/2026 - 05:35 PM EDT Accepted by SEC EDGAR 09/10/2026 - 05:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) is the issuer of common stock covered by a notice filed on behalf of Benjamin Albert under Rule 144. The notice relates to the proposed sale of 35,244 shares of common stock through Morgan Stanley Smith Barney LLC, to be sold on or about September 10, 2026 on NASDAQ.

The filing also lists prior sales of restricted stock by Benjamin Albert during the preceding three months, and states that Health Catalyst, Inc. had 75,256,381 shares of common stock outstanding as of the time indicated.

Key Figures

Shares proposed to be sold: 35,244 shares Aggregate market value of proposed sale: $59,023.13 Shares outstanding: 75,256,381 shares +3 more

6 metrics

Shares proposed to be sold 35,244 shares Common stock to be sold under Rule 144 on or about September 10, 2026

Aggregate market value of proposed sale $59,023.13 Estimated value of 35,244 shares of Health Catalyst, Inc. common stock

Shares outstanding 75,256,381 shares Health Catalyst, Inc. common stock outstanding as referenced in the notice

Shares sold June 1, 2026 336 shares Restricted stock sold for $460.39

Shares sold June 10, 2026 34,485 shares Restricted stock sold for $58,341.72

Shares sold September 1, 2026 321 shares Restricted stock sold for $546.86

Key Terms

Rule 144, Restricted Stock, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 09/10/2026 | Restricted Stock | Health Catalyst, Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Health Catalyst, Inc. (HCAT)?

The Form 144 filing discloses that Benjamin Albert plans to sell 35,244 shares of Health Catalyst, Inc. common stock under Rule 144, with sales expected to be made through Morgan Stanley Smith Barney LLC on or about September 10, 2026 on NASDAQ.

How many HCAT shares is Benjamin Albert proposing to sell under this Form 144?

Benjamin Albert is proposing to sell 35,244 shares of Health Catalyst, Inc. common stock. The filing reports an aggregate market value for these proposed sales of $59,023.13, with the sales expected to occur on or about September 10, 2026 on NASDAQ.

What prior sales of Health Catalyst (HCAT) stock are reported in the past three months?

The filing lists three prior restricted stock sales by Benjamin Albert: 336 shares for $460.39 on June 1, 2026; 34,485 shares for $58,341.72 on June 10, 2026; and 321 shares for $546.86 on September 1, 2026.

What type of securities are being sold in this Health Catalyst (HCAT) Form 144?

The securities are restricted stock of Health Catalyst, Inc. common stock. The proposed sale under Rule 144 covers 35,244 restricted shares, and the filing also reports prior sales of restricted stock during the last three months.

How many Health Catalyst (HCAT) shares were outstanding according to this notice?

The notice states that there were 75,256,381 shares of Health Catalyst, Inc. common stock outstanding at the time indicated in the Form 144, providing context for the size of the proposed and recent sales.

Who is the broker for the planned HCAT stock sale under Rule 144?

The planned sale of Health Catalyst, Inc. common stock is to be executed through Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th Floor, New York, NY 10004, as stated in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002086403
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Benjamin Albert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	35244	59023.13	75256381	09/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2026	Restricted Stock	Health Catalyst, Inc.			35244	09/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/01/2026	336	460.39
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/10/2026	34485	58341.72
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	09/01/2026	321	546.86

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Benjamin Albert
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)